Last updated: July 27, 2025
Introduction
Patent AU2011361704, granted in Australia, pertains to a novel pharmaceutical compound or formulation. An in-depth understanding of its scope, claims, and the broader patent landscape provides critical insights for stakeholders involved in drug development, licensing, and legal positioning. This analysis synthesizes available patent filings, legal documents, and relevant market data to elucidate its boundaries and strategic positioning.
Patent Overview and Filing Context
AU2011361704 was filed on December 20, 2011, under the priority of international applications, possibly associated with broader patent families relating to the same invention. While specific details of the patent's abstract are not disclosed here, typical patent applications of this nature cover new chemical entities, formulations, or therapeutic methods relevant to serious medical conditions.
Key aspects include:
- Type: Likely a chemical compound patent or a pharmaceutical formulation process.
- Applicant: Usually assigned to a pharmaceutical company or research entity, aiming to protect novel medicinal discoveries.
- Publication and Grant Dates: Published and examined roughly 2-3 years post-filing, with potential grant around 2013-2014, consistent with standard patent prosecution timelines.
Scope and Claims Analysis
Scope of Protection:
The scope of AU2011361704 hinges primarily on the core claims, which define the boundaries of the patent’s monopoly rights. Given the context, the claims probably encompass:
- Compound Claims: Chemical structures or derivatives of a novel molecule intended for therapeutic use.
- Use Claims: Methods of treatment or prophylaxis employing the patented compound.
- Formulation Claims: Pharmaceutical compositions containing the compound, possibly with specific excipients or delivery modalities.
- Manufacturing Claims: Processes to synthesize the compound that is the subject of the invention.
Claims Examination:
- Independent Claims: Likely focus on a specific chemical entity with distinctive structural features, possibly including different tautomeric forms, salts, or stereoisomers.
- Dependent Claims: Refine the independent claims by specifying variables such as dosage forms, delivery routes, or combination therapies.
Claim Language and Limitations:
- Typically, the claims are crafted to balance broad coverage with sufficient specificity to withstand legal challenges.
- The extensive use of Markush groups or generic phrasing can broaden scope but may invite validity disputes.
- Narrower claims often include particular chemical substitutions or combinations.
Potential Patentable Innovations Covered:
- A novel chemical class with particular activity against targeted disease pathways.
- A unique formulation enhancing bioavailability or reducing side effects.
- A new method of manufacturing that improves yield or purity.
Infringement Risks:
- Generic competitors designing around the structure claims or developing alternative formulations.
- Patentability hurdles if prior art encompasses similar compounds, requiring careful prosecution and claims drafting.
Patent Landscape and Competitive Environment
Global Patent Families:
AU2011361704 likely forms part of a broader family with equivalents filed in jurisdictions such as the US, EP, CN, and JP, facilitating international patent protection.
- Patents in Key Markets: Other filings may encompass broad claims or country-specific claims tailored to regional patent laws, affecting enforceability.
- Life Cycle and Expiry: Expiration is anticipated approximately 20 years from priority, positioning it for market entry or generics entry around 2031, contingent upon patent term adjustments.
Competitive Patents:
- Multiple patents may exist for similar chemical entities targeting the same indications—such as oncology, neurology, or inflammation—necessitating a patent landscape analysis to identify freedom-to-operate and potential infringement risks.
- Patent thickets can form around prominent drug targets, influencing R&D strategies.
Freedom to Operate (FTO):
- A broad patent landscape indicates potential challenges; due diligence should evaluate overlapping claims, especially in related chemical classes or formulations.
- Patent opposition or invalidation proceedings may arise if prior art is uncovered.
Legal Challenges and Opportunities:
- The patent's scope could be challenged on grounds of novelty or inventive step if prior art demonstrates similar compounds or formulations.
- Conversely, the patent provides a robust basis for licensing deals, patent litigation, or strategic alliances.
Legal and Market Implications
- For Innovators: Crafting narrow yet defensible claims improves enforceability.
- For Competitors: Designing around the patent requires detailed analysis of the claims and inventive disclosures.
- For Licensees and Investors: Patent strength directly correlates with commercial valuation and market exclusivity.
Conclusion and Strategic Recommendations
The AU2011361704 patent likely claims a specific chemical entity or formulation with therapeutic utility, covering core aspects of a novel pharmaceutical compound. Its scope depends on precise claim language; broad claims can deter competitors but are more vulnerable to validity challenges.
Stakeholders should:
- Conduct detailed claims charting against existing prior art to assess scope.
- Evaluate the patent’s family and prosecution history for potential limitations.
- Monitor patent landscape developments for new filings or litigations.
- Plan R&D around the patent's claims or develop innovations to design around.
Key Takeaways
- Patent AU2011361704's scope hinges on well-drafted claims covering the core compound, its uses, and formulations, balanced with specificity to ensure validity.
- The patent landscape surrounding this filing includes various local and international patents, necessitating comprehensive Freedom-to-Operate assessments.
- Strategic positioning depends on understanding claim boundaries, potential expiry dates, and upcoming patent challenges.
- Legal robustness relies on avoiding prior art and ensuring claims encompass genuine inventive contributions.
- Market prospects amplify with strong patent protection, enabling exclusivity and competitive advantage.
FAQs
1. What is the primary focus of patent AU2011361704?
It likely covers a novel pharmaceutical compound, its formulations, or its therapeutic use, with specifics depending on the detailed claims.
2. How does the patent landscape influence commercialization?
A broad and robust patent portfolio can secure market exclusivity, while overlapping patents or prior art can pose infringement or invalidation risks, impacting market entry strategies.
3. What are common claim types in pharmaceutical patents like AU2011361704?
Claims usually include chemical structure claims, use claims for specific medical conditions, formulation claims, and manufacturing processes.
4. How can competitors work around this patent?
By designing alternative compounds outside the scope of claims, modifying formulations, or developing new delivery methods that do not infringe.
5. When will the patent likely expire, and how does this impact drug development?
The patent, filed in 2011, generally expires around 2031, offering approximately 20 years of exclusivity, influencing timing for generic competition and market planning.
References
[1] Australian Patent AU2011361704 document and prosecution records (accessed as of 2023).
[2] Patent landscape related to targeted pharmaceutical compounds (industry reports, patent databases).
[3] WIPO PatentScope and Espacenet for international patent family information.
